白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2015年
4期
203-207
,共5页
白血病,髓样,急性%老年人%治疗%美国血液学会年会
白血病,髓樣,急性%老年人%治療%美國血液學會年會
백혈병,수양,급성%노년인%치료%미국혈액학회년회
Leukemia,myeloid,acute%Aged%Treatment%American Society of Hematology annual meeting
急性髓系白血病(AML)是一种老年性疾病,第56届美国血液学会(ASH)年会上老年人AML治疗是一个焦点,到目前为止,是采用传统化疗方案还是采用去甲基化治疗或采用新药治疗仍然没有定论,文章就此方面进展进行总结.
急性髓繫白血病(AML)是一種老年性疾病,第56屆美國血液學會(ASH)年會上老年人AML治療是一箇焦點,到目前為止,是採用傳統化療方案還是採用去甲基化治療或採用新藥治療仍然沒有定論,文章就此方麵進展進行總結.
급성수계백혈병(AML)시일충노년성질병,제56계미국혈액학회(ASH)년회상노년인AML치료시일개초점,도목전위지,시채용전통화료방안환시채용거갑기화치료혹채용신약치료잉연몰유정론,문장취차방면진전진행총결.
Acute myeloid leukemia (AML) is a disease of the elderly.Treating acute myeloid leukemia in the elderly is the highlight in the 56th American Society of Hematology (ASH) annual meeting.The question of which elderly patients with AML benefit from conventional intensive chemotherapy versus hypomethylating therapy or novel agent remains uncertain.This article reviews the latest research presented at the 56th ASH annual meeting on the elderly AML.
